Results 201 to 210 of about 139,370 (300)

Cerebellar Cystic Metastasis—An Unusual Presentation of Prostate Adenocarcinoma Dissemination: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Although prostate cancer is among the most common malignant tumors in men, brain metastases from prostatic cancer are infrequent. Brain dissemination is especially rare with the most frequent histological type of prostatic adenocarcinoma. We present a case of a cystic‐hemorrhagic cerebellar metastasis with a solid enhancing component in a ...
Mia Smoljan Basuga   +5 more
wiley   +1 more source

Extending Dual Antiplatelet Therapy Beyond 3 Months in Acute Ischemic Stroke Due to Large-Artery Atherosclerosis. [PDF]

open access: yesJ Am Heart Assoc
Lee M   +35 more
europepmc   +1 more source

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 4, Page 928-941, April 2026.
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park   +22 more
wiley   +1 more source

Association of Pregabalin vs. Duloxetine with Cardiovascular Events: A Retrospective Cohort Study Among US Veterans With Chronic Musculoskeletal Pain

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 4, Page 1088-1094, April 2026.
Pregabalin and duloxetine are widely prescribed non‐opioid medications for chronic musculoskeletal pain. Pregabalin may increase the risk of heart failure, and duloxetine increases heart rate and blood pressure; however, little is known about their comparative cardiovascular safety.
Sachalee Campbell   +11 more
wiley   +1 more source

Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy. [PDF]

open access: yesEur Heart J Cardiovasc Pharmacother
Galli M   +9 more
europepmc   +1 more source

Updated evidence on epidemiology, diagnosis, and treatment for colonic diverticular bleeding

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
Abstract Since 2020, multiple large‐scale studies (CODE BLUE‐J) in Japan have accelerated the accumulation of evidence on colonic diverticular bleeding (CDB). This review summarizes the latest findings regarding CDB epidemiology and endoscopic hemostasis.
Chikamasa Ichita   +6 more
wiley   +1 more source

A case of hemobilia caused by a pseudoaneurysm resulting in obstructive cholangitis in a patient who underwent plastic stent placement for pancreatic cancer (with video)

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
Abstract Hemobilia, or hemorrhage within the biliary system, is an uncommon cause of stent obstruction associated with bile duct strictures that are rarely observed with plastic stents. Reports of a pseudoaneurysm as a cause of hemobilia after plastic stent placement are also rare.
Yusuke Seyama   +9 more
wiley   +1 more source

Entering a new era of antiplatelet therapy: the 4D-ACS trial. [PDF]

open access: yesEur Heart J Cardiovasc Pharmacother
Laudani C, Gragnano F, Galli M.
europepmc   +1 more source

A pilot study on anti‐reflux mucoplasty with valve as novel endoscopic therapy for gastroesophageal reflux disease

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
Abstract Background and aims Endoscopic anti‐reflux therapies like anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation have shown efficacy for gastroesophageal reflux disease (GERD) in systematic reviews and meta‐analyses. Anti‐reflux mucoplasty (ARM‐P), a refinement of ARMS, incorporates immediate closure of the resection site to reduce ...
Kazuki Yamamoto   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy